When Mizuho healthcare equity strategist Jared Holz spoke to Barron’s for our annual healthcare roundtable last month, the ...

After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus.

What's the most attractive biotech stock right now for investors? Seeking Alpha analysts ONeil Trader and Terry Chrisomalis ...

Microsoft has backed out of building data centers, Intel's factory opening has been delayed to 2030, but one tech industry is going strong in central Ohio: Biotechnology. The now multibillion dollar ...

Robert Langer, a hugely influential biotech innovator, expects the industry will get through its latest slowdown. He's more worried about the spread of scientific misinformation.

Too many questionable start-ups went public during the pandemic, when the sector was hot. Now, after over four years of pain, ...

Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...

XBI is a biotech-focused ETF offering equal-weight exposure to U.S. biotechnology companies. The SPDR S&P Biotech ETF tracks the performance of the S&P Biotechnology Select Industry Index. XBI ...

A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, ...

Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge's biotech scene so ...